Research and Development

The Research and Development team at Replay Therapeutics plays a crucial role in advancing the company's innovative iPSC therapeutic platform. This team conducts cutting-edge research focused on gene therapy and genome editing, striving to develop hypoimmunogenic solutions that can effectively treat a variety of diseases. Leveraging their diverse expertise, team members collaborate on experimental designs, data analysis, and the development of novel therapeutic strategies to ensure successful translation from bench to bedside.